June is men’s health month. You’ve probably been reminded to ‘get your PSA checked.’ but you may not have heard of a PSMA ...

Mutations in a genetic region that regulates RNA stability could influence prostate cancer outcomes and drug resistance, according to new work from scientists at Fred Hutchinson Cancer Center ...

At the American Urological Association annual meeting, several studies explored the potential role of surgery in managing metastatic prostate cancer. In this exclusive MedPage Today video, Jeremy ...

Prostate-specific membrane antigen (PSMA) is a biomarker that can tell physicians much about a patient’s metastatic prostate cancer. However, in 15–20% of patients with castration-resistant prostate ...

Every year, hundreds of thousands of men receive a prostate cancer diagnosis and immediately face a decision that medical ...

Genomic classifier (GC) tests do not appear to consistently influence risk classification or treatment decisions for patients with newly diagnosed prostate cancer considering first-line treatment, ...

Scientists have learned that prostate cancers can vary significantly among patients and that there are often differences within each patient's tumor. However, the study published Aug. 28 in Nature ...

NEW HAVEN, Conn. (WTNH) — Understanding prostate cancer and the role genetics play can be very important for your health. With one in nine men affected by this disease, scientists at Hartford ...

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who is most ...

The advent of more effective treatment combinations for metastatic hormone-sensitive prostate cancer (mHSPC) has been built on successes in therapy development for metastatic, castration-resistant ...